Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages E550-E560

  Duparc, Céline ^a,b,c   Moreau, Lucile ^a,b,c,d   Dzib, Jose Felipe Golib ^e   Boyer, Hadrien Gaël ^a,b,c   Nomigni, Milène Tetsi ^a,b,c   Boutelet, Isabelle ^a,b,c   Boulkroun, Sheerazed ^f,g   Mukai, Kuniaki ^h   Benecke, Arndt G ^e   Amar, Laurence ^f,g,i   Gobet, Françoise ^d   Meatchi, Tchao ^f,g,i   Plouin, Pierre François ^f,g,i   Zennaro, Maria Christina ^f,g,i   Louiset, Estelle ^a,b,c   Lefebvre, Hervé ^a,b,c,d  

^a NORMANDIE UNIVERSITÉ   (France)

^b UNIVERSITY OF ROUEN   (France)

^c UNIVERSITÉ DE ROUEN   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e CNRS   (France)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE;

ADRENAL CORTEX; ADRENAL CORTEX CELL; ADULT; ALDOSTERONE RELEASE; ARTICLE; CELL CULTURE; CELL DENSITY; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYP11B2 GENE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MAST CELL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOMA; ADRENAL CORTEX TUMOR; CELL COUNT; CELL PROLIFERATION; COMPLICATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HYPERALDOSTERONISM; HYPERPLASIA; METABOLISM; MICROARRAY ANALYSIS; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SECRETION (PROCESS);

ADENOMA; ADRENAL CORTEX NEOPLASMS; ALDOSTERONE; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; MAST CELLS; MICROARRAY ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84927636946     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3660     Document Type: Article

References (42)

1. Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient's cohorts and in population-based studies-a review of the current literature. Horm Metab Res. 2012;44(3):157-162.
2. + channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331(6018):768-772.
3. Boulkroun S, Beuschlein F, Rossi G-P, et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 2012;59(3):592-598.
4. Scholl UI, Goh G, Stölting G, et al. Somatic and germlineCACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45(9):1050-1054.
5. Beuschlein F, Boulkroun S, Osswald A, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45(4):440-444, 444e1-2.
6. O'wald A, Fischer E, Degenhart C, et al. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients. Eur J Endocrinol. 2013;169(5):657-663.
7. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. 1998;19(2):101-143.
8. Lefebvre H, Compagnon P, Contesse V, et al. Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT. J Clin Endocrinol Metab. 2001;86(10):5001-5007.
9. Aiba M, Iri H, Suzuki H, et al. Numerous mast cells in an 11-deoxycorticosteroneproducing adrenocortical tumor. Histologic evaluation of benignancy and comparison with mast cell distribution in adrenal glands and neoplastic counterparts of 67 surgical specimens. Arch Pathol Lab Med. 1985;109(4):357-360.
10. Louiset E, Isvi K, Gasc JM, et al. Ectopic expression of serotonin 7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol. Endocr Relat Cancer. 2008;15(4):1025-1034.
11. Cartier D, Jégou S, Parmentier F, et al. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. Eur J Endocrinol. 2005;153(6):939-947.
12. Lefebvre H, Cartier D, Duparc C, et al. Characterization of serotonin (4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies. J Clin Endocrinol Metab. 2002;87(3):1211-1216.
13. Ye P, Mariniello B, Mantero F, Shibata H, Rainey WE. G-proteincoupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J Endocrinol. 2007;195(1):39-48.
14. Lampron A, Bourdeau I, Oble S, et al. Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma. J Clin Endocrinol Metab. 2009;94(3):750-756.
15. Zwermann O, Suttmann Y, Bidlingmaier M, Beuschlein F, Reincke M. Screening for membrane hormone receptor expression in primary aldosteronism. Eur J Endocrinol. 2009;160(3):443-451.
16. Maltby S, Khazaie K, McNagny KM. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta. 2009;1796(1):19-26.
17. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med. 2007;13(10):1211-1218.
18. Dahl C, Saito H, Kruhøffer M, Schiøtz PO. Identification of tryptaseand chymase-related gene clusters in human mast cells using microarrays. Allergy. 2006;61(3):276-280.
19. Bécavin C, Tchitchek N, Mintsa-Eya C, Lesne A, Benecke A. Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition. Bioinformatics. 2011;27(10):1413-1421.
20. Brysbaert G, Pellay F-X, Noth S, Benecke A. Quality assessment of transcriptome data using intrinsic statistical properties. Genomics Proteomics Bioinformatics. 2010;8(1):57-71.
21. Tchitchek N, Dzib JFG, Targat B, Noth S, Benecke A, Lesne A. CDS: a fold-change based statistical test for concomitant identification of distinctness and similarity in gene expression analysis. Genomics Proteomics Bioinformatics. 2012;10(3):127-135.
22. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res. 1988;12(4):345-355.
23. Kirshenbaum AS, Akin C, Wu Y, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 es tablished from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leuk Res. 2003;27(8):677-682.
24. Louiset E, Duparc C, Young J, et al. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med. 2013;369(22):2115-2125.
25. Boulkroun S, Samson-Couterie B, Dzib J-FG, et al. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension. 2010;56(5):885-892.
26. Nishimoto K, Nakagawa K, Li D, et al. Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab. 2010;95(5):2296-2305.
27. Fernandes-Rosa FL, Williams TA, Riester A, et al. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension. 2014;64(2):354-361.
28. Yang F-C, Ingram DA, Chen S, et al. Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell. 2008;135(3):437-448.
29. Amini R-M, Aaltonen K, Nevanlinna H, et al. Mast cells and eosinophils in invasive breast carcinoma. BMC Cancer. 2007;7:165.
30. Yano H, Kinuta M, Tateishi H, et al. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer. 1999;2(1):26-32.
31. Marichal T, Tsai M, Galli SJ. Mast cells: potential positive and negative roles in tumor biology. Cancer Immunol. Res. 2013;1(5):269-279.
32. Ono Y, Nakamura Y, Maekawa T, et al. Different expression of 11β-hydroxylase and aldosterone synthase between aldosteroneproducing microadenomas and macroadenomas. Hypertension. 2014;64(2):438-444.
33. Nanba K, Tsuiki M, Sawai K, et al. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J Clin Endocrinol Metab. 2013;98(4):1567-1574.
34. Nakamura Y, Maekawa T, Felizola SJA, et al. Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies. Mol Cell Endocrinol. 2014;392(1-2):73-79.
35. Bassett MH, White PC, Rainey WE. A role for the NGFI-B family in adrenal zonation and adrenocortical disease. Endocr Res. 2004;30(4):567-574.
36. Hattangady NG, Olala LO, Bollag WB, Rainey WE. Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol. 2012;350(2):151-162.
37. Xing Y, Rainey WE, Apolzan JW, Francone OL, Harris RBS, Bollag WB. Adrenal cell aldosterone production is stimulated by very lowdensity lipoprotein (VLDL). Endocrinology. 2012;153(2):721-731.
38. Liu W, Shimada M, Xiao J, Hu D, Matsumori A. Nifedipine inhibits the activation of inflammatory and immune reactions in viral myocarditis. Life Sci. 2009;85(5-6):235-240.
39. Conti P, Castellani ML, Kempuraj D, et al. Role of mast cells in tumor growth. Ann Clin Lab Sci. 2007;37(4):315-322.
40. Halova I, Draberova L, Draber P. Mast cell chemotaxis-chemoattractants and signaling pathways. Front Immunol. 2012;3:119.
41. Schjerning J, Uhrenholt TR, Svenningsen P, et al. Histamine-dependent prolongation by aldosterone of vasoconstriction in isolated small mesenteric arteries of the mouse. Am J Physiol Heart Circ Physiol. 2013;304(8):H1094-H1102.
42. Xiao J, Shimada M, Liu W, Hu D, Matsumori A. Anti-inflammatory effects of eplerenone on viral myocarditis. Eur J Heart Fail. 2009;11(4):349-353.